Rohto Pharmaceutical

Summary

Rohto Pharmaceutical appeared to be the Corporate Investor, which was created in 1949. The fund was located in Asia if to be more exact in Japan. The main office of represented Corporate Investor is situated in the Osaka.

The top activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars.

For fund there is a match between the location of its establishment and the land of its numerous investments - Japan. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Sasta Sundar, FiNC, FiNC. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Beauty. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Rohto Pharmaceutical, startups are often financed by Dai-ichi Life, Yoshinoya Holdings, Saison Ventures. The meaningful sponsors for the fund in investment in the same round are Dai-ichi Life, Yoshinoya Holdings, Saison Ventures. In the next rounds fund is usually obtained by Dai-ichi Life, Mirai Creation Fund, Meiji Yasuda Life Insurance Co..